Heal initiative: research to foster an opioid use disorder treatment system patients can count on - 0BPROJECT summary/abstract opioid overdose deaths reached the highest level ever in 2021

Active Project Grant Awarded Last action

Award ID
RM1DA059375
Recipient
Awarding agency
Obligated
$9,474,490

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 62% complete
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Description

Medications to treat opioid use disorder (moud) can markedly reduce overdose risks when taken for long enough. More than 650,000 people receive moud in opioid treatment programs (otps) annually. Unfortunately, on average, less than half of patients stay in opioid use disorder (OUD) treatment for the recommended minimum 1 year of time. OTP retention and outcome quality measures (i.e., "audit and feedback") may improve treatment retention rates and outcomes. Quality measures can also help monitor the effect of new OTP reimbursement and regulatory policies. Eventually, OTP quality measures could be incorporated into the federal government's public facing healthcare provider compare website. However, research is needed to determine how to most effectively create and disseminate OTP quality measures. The literature on audit and feedback points to three features that influence the probability that measures will result in improved quality: (1) the characteristics of the measures and benchmarks, (2) the knowledge that providers have about how to improve the measures, and (3) the control that providers have over the factors that matter to improve the measure. This study will test approaches for optimizing each of these factors. Nida RFA-DA-23-046 is supporting multi-project OUD quality measurement and management research centers that pair researchers with partner organizations that have an OUD quality measurement and management strategy that research could advance. RTI international, university of california LOS angeles, and beacon health connecticut are the research organizations leading this study. They are partnering with two organizations that need to develop an effective OTP quality measurement and management system: baymark health services and the LOS angeles county division of substance abuse prevention and control. The team is implementing three inter-related research projects with the following overall aims: overall aim 1. Create and psychometrically test OTP measures of retention, overdose emergency department visits, overdose hospitalizations, and mortality with benchmarks and toolkits describing how otps can improve retention. Overall aim 2. Test the effect of the giving otps quality measures and information on how to improve retention (a retention toolkit), with and without quality improvement training, by conducting a clustered randomized trial that assigns otps to receive either: (1) retention and outcome measures with the toolkit; or (2) retention and outcome meaures with the toolkit as well as quality improvement (QI) training (i.e., niatx) (arm 2), or (3) treatment as usual (control arm). Overall aim 3. Test the effect of aligning OTP-level and LA county population-level OUD measures on retention and outcomes in LA county relative to other counties in california.

Transactions

Action Obligated Date
Amendment $1,414,928
Amendment $0
Amendment $0
Amendment $1,583,828
Amendment $1,583,828
Amendment $0
Amendment $0
Amendment $1,812,332
Amendment $0
Amendment $0
Amendment $1,539,787
Original award $1,539,787
Show all 12

Subawards

Subrecipient Amount Awarded
Medical University Of South Carolina PO RTI1008343 Subcontract 684 $42,907
Centers For Medicare & Medicaid Services PO RTI10000848 $50,500
Baymark Health Services Inc. 1-312-0219298 Mod 1 $13,131
University Of California, LOS Angeles Subcontract 2-312-0219298 Mod 2 161,960 dtd 11-24-24 and 1/2 of Mod 3 (deobligation) dtd 3-10-2024 -149419 = 12541 (deobligation too big to only deduct from 1… $12,541
University Of California, LOS Angeles Subcontract 2-312-0219298 Mod 1 $151191 dtd 10-22-24 and Mod 3 (B) dtd 3-10-2025 deoblig -100,000 = $51,191 (Mod 3 was too big to deduct from 1 funding… $6,284
University Of California, LOS Angeles Subcontract 2-312-0219298 Initial Award $155,191
Baymark Health Services Inc. Subcontract 1-312-0219298 Initial Award $148,450

Quick answers

Who received award RM1DA059375?

RM1DA059375 was awarded to Research Triangle Institute by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2023.

How much is award RM1DA059375 worth?

$9,474,490 has been obligated on RM1DA059375.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award